
|Articles|May 1, 2002
- Volume 0 0
Bulking Up on Fiber Does Not Cause GI Problems
Advertisement
The benefits of a fiber-rich diet can be achieved without uncomfortable gastrointestinal side effects, a new study has shown. Approximately 1,300 women were asked to consume at least 30 g of fiber daily (35 g of fiber per day is recommended as the upper limit by the US National Cancer Institute). The increased fiber intake was not linked to bloating, upset stomach, or diarrhea, the study authors reported in the April 2002 issue of the Journal of the American Dietetic Association.
Articles in this issue
over 24 years ago
HOT OTC Introductions in 2001over 24 years ago
Making the "White" Choice: OTC Tooth-Whitening Productsover 24 years ago
Norelgestromin/ Ethinyl Estradiol (Ortho Evra)over 24 years ago
Lawyers Have Latitude in Closing Argumentsover 24 years ago
Incomplete Directions Can Lead to Dispensing Errorsover 24 years ago
Pharmacodynamic Drug Interactions with Ziprasidoneover 24 years ago
An Update on Hepatitis Cover 24 years ago
Medication Advice for Travelersover 24 years ago
Allergic Rhinitis: A Focus on Nonprescription Therapyover 24 years ago
Animal Protein May Protect Bone Mineral DensityAdvertisement
Related to this article

Pharmacists can use medication therapy management to screen for diabetes, educate patients about medication adherence and lifestyle modifications, and support early action.

Higher doses of injectable semaglutide have been shown to cause greater weight loss than standard doses with a similar safety profile.

In every practice setting, pharmacists can meet vaccine hesitancy with evidence, effective communication, and vetted resources that move patients toward “yes.”

Retail pharmacists use a quick checklist to spot risky antithrombotic duplicates, dosing mistakes, OTC interactions, and adherence gaps—helping prevent stroke and bleeding.

Health-system pharmacists confirm therapy matches stroke mechanism, screen for bleeding risk and drug interactions, and help patients transition to outpatient care.

Peer Reviewed
Identifying and screening Medicare Part D patients who are ordered brand-name cardiovascular medications for PACE/PACENET eligibility before discharge can reduce patients’ out-of-pocket costs for these medications.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Two-Drug HIV Regimens, Archived M184V Resistance, and Long-Acting Preference
2
Long-Acting HIV Injectables in Viremia and New Tenofovir-Free Oral Options
3
SNO 2026 Roundup: What Longer Follow-Up Means for Targeted Glioma Care
4
Overton FDA Nomination Withdrawn: What It Means for Pharmacists
5


